Skip to Main Content

Paper Details

Fragment- and structure-based drug discovery for developing therapeutic agents targeting the DNA Damage Response.
Prog Biophys Mol Biol
16
2021
Author NameAffiliation
Ashley M DeaconAccelero Biostructures Inc., USA XPose Therapeutics Inc.
Andrew P YehAccelero Biostructures Inc.
John A TainerMD Anderson Cancer Center
Debanu DasAccelero Biostructures Inc., USA XPose Therapeutics Inc.
  • 1 - 4

Datasets

Release 1.2